LiDa DAIDAIHUA — Class I drug recall D-0296-2016
Terminated recall by Blue Square Market, Inc., reported 2015-11-25, distributed nationwide. Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.
| Recall number | D-0296-2016 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Blue Square Market, Inc., North Huntingdon, PA, United States |
| Recall initiated | 2015-08-06 |
| Classified | 2015-11-17 |
| Reported by FDA | 2015-11-25 |
| Terminated | 2018-10-18 |
| Distributed | Nationwide (US) |
| Quantity | 25 boxes |
| Reason classes | undeclared allergen, unapproved product |
Product
LiDa DAIDAIHUA (also packaged as LiDa DAIDAIHUAJIAONANG), capsules, packaged in 1.6oz box 30 capsules per box, Kunming Dali Industry & Trade Co., Ltd
Reason for recall
Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0296-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.